Yesterday, I talked about how “watchful waiting”—instead of active treatment—often makes the most sense for men diagnosed with low-risk prostate cancer. But there’s one HUGE potential problem [...]
Yesterday, I talked about how “watchful waiting”—instead of active treatment—often makes the most sense for men diagnosed with low-risk prostate cancer. But there’s one HUGE potential problem [...]
Hearing the words, “you have prostate cancer” is enough to send ANY man down a dark tunnel of anxiety and depression, worry and despair. And with good reason… Mainstream solutions—like [...]
Prostate cancer is a huge worry for men. And rightly so—as one out of every nine men will be diagnosed with it at some point in their lives. Although, in most cases, these men really have what I [...]
It’s really no wonder why prostate cancer remains the No. 1 cancer in American men today! The disease gets short shrift when it comes to research and funding into prevention, screening and [...]
Prostate cancer has been the “poster boy,” so to speak, of the cancer overdiagnosis and overtreatment epidemic. Especially when you consider that the science shows watchful waiting (or [...]
As I started reporting last summer, coronavirus panic caused many patients to put off seeking much-needed medical care. It also caused an almost-complete shutdown of routine cancer screenings for [...]
We tend to think of prostate cancer as a disease that affects older men. In fact, you may often hear that men older than 70 usually die with prostate “cancer,” not because of it. But according to [...]
The mainstream cancer research industry treats prostate cancer (and men’s health in general) almost as an afterthought. As I often report, the dreadful prostate specific antigen (PSA) screening [...]
Men’s health issues are underfunded and overlooked by mainstream medicine—especially prostate cancer. In fact, as I’ve written here before, the mainstream still relies on the flawed and outdated [...]
The mainstream can’t stop talking about the new drug lutetium (Lu-177). They’re even calling it a potential “major breakthrough” for metastatic prostate cancer. But I’m quite wary to buy into the [...]